The report "Flexible Endoscopes Market by Type (Colonoscope, Laryngoscope, Bronchoscope, Other Types), Application (Laparoscopy, Mediastinoscopy, Obstetrics, Arthroscopy, Cystoscopy, Mediastinoscopy), End User (Hospitals, ASCs, Clinics), and Region – Global Forecast to 2030", is projected to reach USD 3.07 billion by 2030, growing from USD 2.38 billion in 2025, at a CAGR of 5.1% from 2025 to 2030.
Browse 443 market data Tables and 48 Figures spread through 329 Pages and in-depth TOC on "Flexible Endoscopes Market by Type (Colonoscope, Laryngoscope, Bronchoscope, Other Types), Application (Laparoscopy, Mediastinoscopy, Obstetrics, Arthroscopy, Cystoscopy, Mediastinoscopy), End User (Hospitals, ASCs, Clinics), and Region – Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/flexible-endoscopes-market-148138146.html
The growth of the flexible endoscopes market is driven by the increasing procedural volumes due to rising chronic gastrointestinal, pulmonary, and urological conditions and the growing patient preference for minimally invasive diagnostics. Additionally, a surge in day-care endoscopy centers and a shift toward outpatient procedures are accelerating demand.
Opportunities for players in the market lie in developing cost-effective disposable endoscopes to combat infection risks, rising penetration in underdeveloped healthcare markets, and integration of AI-driven analytics and robotics for real-time diagnostics, which enhance accuracy and clinical decision-making across broader care settings.
The upper gastrointestinal videoscope subsegment accounted for the largest share in 2024.
By type, the flexible endoscopes market is segmented into upper gastrointestinal endoscopes, colonoscopes, broncoscopes, sigmoidoscopes, laryngoscopes, pharyngoscopes, duodenoscopes, nasopharyngoscopes, rhinoscopes, and other types. The upper gastrointestinal endoscopes segment accounted for the largest market share in 2024. The segment is further divided into upper gastrointestinal videoscope and upper gastrointestinal fiberscope. Among these, the upper gastrointestinal videoscope segment accounted for a significant market share in 2024, due to the critical role of upper gastrointestinal videoscope in diagnosing and treating a wide range of upper GI conditions, such as GERD, ulcers, Barrett’s esophagus, and gastric cancers. These devices utilize advanced video chip technology that delivers high-resolution, real-time imaging, enabling accurate diagnosis and guided therapeutic interventions. Their flexibility allows for precise navigation through complex anatomical regions, which makes them essential in procedures like foreign object removal, biopsies, and bleeding control. Moreover, their extensive use in hospital and outpatient settings, supported by skilled professionals and ongoing technology upgrades, further solidifies their dominant market position within the flexible endoscopes market.
The hospitals segment accounted for the largest share in 2024.
By end user, the flexible endoscopes market is segmented into hospitals, ambulatory surgical centers (ASCs), clinics, and other end users (Diagnostic centers, mobile endoscopy facilities, and office-based endoscopy service providers). Among these, the hospitals segment accounted for the largest market share in 2024, owing to the high patient inflow for diagnostic and therapeutic procedures, which demand advanced infrastructure and skilled medical professionals. Hospitals are equipped with comprehensive surgical setups, enabling the use of flexible endoscopes across various specialties, such as gastroenterology, pulmonology, and urology. Additionally, increasing funding from both public and private sectors has supported hospitals in upgrading to next-generation endoscopic equipment, improving procedural efficiency and outcomes. Hospitals often serve as referral centers for complex cases, increasing the volume of endoscopic procedures. These factors collectively drive hospital-based endoscopy adoption, reinforcing the dominant position of the hospitals segment in the market.
North America dominated the global flexible endoscopes market in 2024
The flexible endoscopes market is segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global flexible endoscopes market due to the high prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological conditions, which require frequent diagnostic and therapeutic endoscopic procedures. According to the CDC (October 2024), six in ten Americans have at least one chronic disease, and four in ten suffer from multiple conditions, significantly driving the demand for minimally invasive solutions, like flexible endoscopes. Additionally, the region benefits from the strong presence of key endoscope manufacturers and continuous technological innovation. The region’s well-established healthcare infrastructure, favorable reimbursement policies, and high awareness among patients and physicians further contribute to the region's early adoption of endoscopic procedures. Moreover, the increasing investment by healthcare facilities in upgrading diagnostic capabilities and the presence of trained professionals reinforce North America’s leadership in the flexible endoscopes market.
Key Players
Some of the prominent players operating in the market include Olympus Corporation (Japan), Karl STORZ SE & Co. KG (Germany), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), HOYA Corporation (Japan), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), and Ambu A/S (Denmark).